A research report blasting Intuitive Surgical (NSDQ:ISRG) spooked investors on Wall Street yesterday and today, prompting a selloff that’s shaved some 11% from the medical device company’s share price.
Intuitive Surgical
Funding: SurgiQuest locks up $18.5 million
SurgiQuest closed an $18.5 million Series D financing round, raising funds through a mix of equity and debt financing.
The Milford, Conn.-based medical device company develops technology for laparoscopic procedures, with features designed to remove electrosurgical smoke and keep endoscopic imaging instruments’ field of vision clear.
Abbott’s board approves AbbVie pharma spinout | Wall Street Beat
Abbott (NYSE:ABT) said its board of directors approved the spinout of its branded pharmaceuticals business as AbbVie Inc. in which Abbott’s shareholders will receive an AbbVie share for each ABT share they own.
The distribution is slated for Jan. 1, 2013, for shareholders of record as of Dec. 12, according to a press release.
Survey: Heart docs say Edwards on track for solid heart valve growth | Wall Street Beat
Edwards Lifesciences (NYSE:EW) is on track for solid growth in the transcatheter aortic valve implant market, according to a survey of cardiologists conducted by Leerink Swann analysts.
Robotics: Hansen gains 25% on $30M deal with Intuitive Surgical
OmniGuide saddles up for some scale
MassDevice.com first visited OmniGuide in 2009, when the Cambridge, Mass.-based medical device company was developing the BeamPath laser scalpel, aiming for 2 orders of magnitude more precision than the most precise soft-tissue cutting tool.
Today the company has refined that technology even further and has turned its focus toward ramping up commercialization of the BeamPath device, CEO Scott Flora told us this month.
Intuitive Surgical slides after hours on lower procedure volumes
Intuitive Surgical (NSDQ:ISRG) delivered another Street-beating quarter today, but investors, spooked by sliding procedure volumes, shaved more than 5% from its share price in after-hours trading.
Doc accused of falsifying data on NMT Medical’s StarFlex | MassDevice.com On Call
MASSDEVICE ON CALL — The U.K.’s Medical Practitioners Tribunal Service will convene later this month to consider accusations against Dr. Michael Mullen and charges that he knowingly falsified data in a trial of NMT Medical’s StarFlex device as an effective treatment for migraines.
Angels in America: Early-stage investment rebounds | Wall Street Beat
Angel investors started to come out of their shells during the first half of the year with angel investments up more than 3% compared with H1 2011, according to research out of the University of New Hampshire, and medical device companies took the lion’s share of the backing.
The medical device and equipment sector grabbed 24% of total angel investment during the first six months of the year, according to a study from UNH’s Center for Venture Research.
Intuitive Surgical sued over heart stabilizer patent
Intuitive Surgical‘s(NSDQ:ISRG) da Vinci surgical robot infringes at least 1 claim of a patent owned by Alisanos LLC, according to a lawsuit.
Biomet M2A Magnum hip implant lawsuits consolidated in Indiana
A raft of personal injury lawsuits filed over Biomet‘s M2A Magnum metal-on-metal hip implant have been consolidated in a federal court in Indiana.
The U.S. Judicial Panel on Multidistrict Litigation moved 65 pending cases from other jurisdictions to the U.S. District Court for Northern Indiana, over Biomet’s objections.